Since procaine has both local anaesthetic and central stimulant actions its presence in the blood or urine of racing horses is forbidden. After rapid intravenous injection of procaine HCI (2.5 mg/Kg) in thoroughbred mares plasma levels of this drug fell rapidly (th/2e = 5 min)* and then more slowly (t1/43 = 50.2 min).* These kinetics were well fitted by a two compartment open model (Model I). This model gave an apparent Vdp for procaine in the horse of about 3,500 litres. Since procaine was about 45% bound to equine plasma protein this gives a true VdP for procaine of about 6,500 litres.
levels are about one-twentieth of those associated with marked CNS excitation in humans. The horse is thus at least twenty-fold more sensitive to the central stimulant action of procaine than is the human.
I ntroduction
The pharmacokinetics and behavioural effects of procaine in the horse are of forensic importance because the presence of procaine in the blood and urine of racing animals is forbidden by most racing authorities (MeyerJones, 1951) . The pharmacokinetics of procaine are further complicated by the routes and forms in which procaine may be administered to racehorses. Thus, procaine may be administered subcutaneously or intramuscularly for its local anaesthetic action associated with minor surgery. Alternatively, it may be given intramuscularly in relatively large amounts as procaine penicillin. These uses of procaine are common in equine medicine and surgery and are, per se, quite acceptable to racing authorities.
Other possible uses of procaine are regarded with disfavour by racing authorities. These include the use of small amounts of procaine to produce nerve blocks and the direct injection of procaine into inflamed joints. Both these techniques permit a horse with joint or tendon problems to improve its performance and may thus affect the outcome of a race.
Another less clear-cut aspect of the use of procaine in racing horses is the belief that central effects produced by high levels of procaine are stimulant in nature and may positively affect the courage or performance of racing horses (Meyer-Jones, 1951) . No clear-cut experimental evidence is available at present in this area, but this possibility, combined with the well characterized uses of procaine to alleviate lameness, has led racing 110 authorities to ban the use of procaine or procainecontaining preparations in horses about to be raced. B e cause of these considerations horsemen, veterinarians and racing authorities require information concerning the pharmacology, pharmacokinetics and behavioural effects of procaine in horses. These studies were undertaken in an attempt to provide answers to these questions. The pharmacokinetic analysis was performed as described by Kostenbauder etal. (1975) using the SAAM-23 programme (Berman and Weis, 1968) . Full reports on the experiments reported here and the methods used are to be published elsewhere (Tobin et al. 1975 (Tobin et al. , 1976a ).
For detection and quantification of procaine we use Brodie's method, a colour density technique using ethylene diamine. It would not detect para-amino-benzoic acid, as this compound is not extracted at the pH = 8 that we use. Our horses are all in stables, and this produces an alkaline urine. Freshly drawn whole equine blood was incubated in 15 ml aliquots at 370 with constant shaking (Tobin et al., 1976b) . At indicated zero time the reaction was started by the addition of 3 pg/ml of procaine HCI. The reaction was stopped when required by the addition of arsenite and eserine, the plasma separated and the procaine levels in plasma estimated as previously. All points are the means of three experimental determinations on different blood samples (from Tobin et al., 1976b ).
Because of the well known sensitivity of procaine to hydrolysis by human plasma (Brodie et al., 1948) , we first studied the hydrolysis of this drug by equine blood. Figure 1 shows the rate of hydrolysis of 2 gg/ml of procaine added to freshly drawn equine blood in vitro at 370C. Under these conditions the added procaine was hydrolysed with an apparent half-life of about 9 minutes at 370C. Other experiments (Tobin et al., 1976b) showed that the hydrolytic activity was due to plasma esterases. Though this hydrolysis in equine blood occurs at about one-tenth of the rate observed in human blood (Brodie et al., 1948) , this reaction is still sufficiently rapid for it to be an important pathway of procaine metabolism, both in vivo and in vitro. Standardbred and other horses to determine this variability. The data presented in Fig. 3 shows that the mean rates of hydrolysis among the different groups of horses tested were very similar and that the overall variability encountered was that which might be expected in a single population [see insert, Fig. 3 ]. Figure 4 shows the blood levels of procaine observed after the rapid intravenous administration of 2.5 mg/kg of procaine to Thoroughbred horses. Plasma levels of procaine declined rapidly at first with an initial or a phase half-time of about 5 minutes. Thereafter, however, the decline was relatively slow, with a phase half-time of about 50 minutes. These data are well fitted by the two compartment open model outlined in Fig. 4 and the solid line in Fig. 4 is that obtained from the equations describing this model (Table 1) . The slow plasma half-life for procaine (50 minutes) was unexpected in view of the observation that procaine is hydrolyzed relatively rapidly in equine blood and suggests wide distribution of procaine in the body of the horse. This conclusion is supported by the observation that the calculated volume of distribution (VdMO) of procaine in these horses is 6.71 litres/kg, i.e. procaine distributes into an apparent volume about 7 times greater than the volume of the horse (Table 1) . Procaine is often administered subcutaneously or intramuscularly in horses for its local anaesthetic action during minor surgery. Figure 5 shows that when given subcutaneously blood levels of procaine rise rapidly and then decline with a half-life of about one hour. Similarly, when procaine was injected intramuscularly (Fig.  6) blood levels of the drug again peaked rapidly and declined somewhat more slowly, with an apparent halflife of about two hours. The experiments show that when given by either of these routes blood levels of procaine peak and then clear relatively rapidly (Table   11 ).
After the intramuscular administration of procaine to horses in the experiments of Fig. 7 , signs of central nervous system stimulation were observed in some of these horses. This was rather surprising since Usubiaga et al. (1966) reported that procaine plasma levels of up to 40 ng/ml are required in the human to produce signs of CNS excitation. We therefore infused a number of horses with procaine to determine the relationship between plasma levels of procaine and CNS excitation in the Thoroughbred horse. The data of Fig. 7 show that mild signs of excitement become apparent at plasma procaine Figure 8 shows blood levels of procaine observed after the intra-articular injection of procaine hydrochloride and the intramuscular injection of procaine penicillin. The experiment shows that after the intraarticular injection of procaine, blood levels of procaine again rose and then declined rapidly. In contrast, however, after procaine penicillin blood levels of procaine reached a peak relatively slowly and then declined very slowly indeed, with a half-life in the order of about 10 hours. These experiments suggest that though it is not possible to distinguish chemically between procaine given as procaine HCI and that given as procaine penicillin, it may be possible to distinguish between these drugs on the basis of their pharmacokinetics. Thus in a horse "called" for procaine the drawing of subsequent blood samples should show slowly decreasing plasma levels of procaine in animals which were treated with procaine penicillin, but more rapidly declining or probably no plasma levels at all in horses which were treated with procaine hydrochloride. The relationship between blood and urinary levels of procaine in the horse is complex and, at this time, only partially characterized. Figure 9 shows the blood and urine levels of procaine observed after a single intravenous injection of procaine. While the blood levels of procaine fell rapidly, as described previously, urinary levels of the drug declined very slowly. Figure 10 shows similar results obtained after the intramuscular injection of procaine. In this experiment, blood levels of procaine declined with a half-life of about 2.0 hours, consistent with the experiments of urinary levels of the drug are in evidence long after the drug is no longer detectable in blood. The reasons for this very slow rate of decay of urinary levels of the drug are not clear, but sequestration of the drug in the kidney or urinary tract is presumably involved.
In conclusion, procaine is relatively rapidly hydrolyzed in equine plasma and this hydrolysis is blocked by eserine or cooling plus oxalate and fluoride. Procaine has a metabolic or d3 phase half-life in the horse of about 50 minutes. This relatively long half-life is due to wide distribution and tissue binding of this drug in the horse. When administered as procaine by any route, its half-life in the bloodstream of the horse is relatively short, usually about 2.0 hours or less. When administered as procaine penicillin its half-life is about 10 hours. This suggests that it may be possible to distinguish pharmacokinetically between procaine given in these forms. For reasons which are currently unclear, procaine is found in the urine of horses long after it has disappeared from their bloodstreams, a finding which may be of some forensic importance. BLAKE: It depends on how soon, following the administration of procaine penicillin, it is tested. We do have an electron capture method for penicillin G. and if procaine is present, we have to assume it was given as procaine penicillin, but the only realistic way is to take multiple blood samples, not realistic on a racetrack. TOBIN: If Blake finds a positive he would ask for another sample from that horse immediately. If it was procaine penicillin we would still expect to find it in the plasma, if it was procaine HCI it should be undetectable.
MAYNARD: There are preparations which contain both procaine hydrochloride and procaine penicillin. TOBIN: What is the procaine HCI in the preparation for? It would seem to be pharmacologically unnecessary.
ROBSON: The chief use of procaine in humans is that penicillin salts by themselves cause local pain that may be present for a period of several hours, and procaine was introduced as a local anaesthetic to prevent the injection mass being painful.
TOBIN: I understood the reason is to delay absorption.
JAGGARD: Have you done any work yet with azomycin? We have found that it will stay in the horse's urine for 3 to 4 days possibly because of buffers, lecithin and other ingredients in the formulation. TOBIN: We find procaine penicillin, after intramuscular injection, in the urine for 2 weeks under experimental conditions. 
